Forsta Ap Fonden Amgen Inc Transaction History

Forsta Ap Fonden

$13.7 Billion
Q4 2024

A detailed history of Forsta Ap Fonden transactions in Amgen Inc stock. As of the latest transaction made, Forsta Ap Fonden holds 126,400 shares of AMGN stock, worth $34.8 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

126,400

Previous 130,600 3.22%

Holding current value

$34.8 Million

Previous $42.1 Million 21.71%

% of portfolio

0.24%

Previous 0.33%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 23, 2025	SELL	$258.78 - $328.31 $1.09 Million - $1.38 Million	-4,200 Reduced 3.22%	126,400 $32.9 Million
Q3 2024 Oct 24, 2024	BUY	$309.38 - $337.38 $247,504 - $269,904	800 Added 0.62%	130,600 $42.1 Million
Q2 2024 Aug 08, 2024	SELL	$262.75 - $319.31 $3.52 Million - $4.28 Million	-13,400 Reduced 9.36%	129,800 $40.6 Million
Q1 2024 May 07, 2024	BUY	$268.87 - $324.56 $4.49 Million - $5.42 Million	16,700 Added 13.2%	143,200 $40.7 Million
Q4 2023 Feb 06, 2024	SELL	$255.7 - $288.46 $588,110 - $663,458	-2,300 Reduced 1.79%	126,500 $36.4 Million
Q3 2023 Oct 25, 2023	SELL	$218.65 - $271.46 $262,380 - $325,752	-1,200 Reduced 0.92%	128,800 $34.6 Million
Q2 2023 Aug 03, 2023	SELL	$214.27 - $253.37 $1.76 Million - $2.08 Million	-8,200 Reduced 5.93%	130,000 $28.9 Million
Q1 2023 Apr 21, 2023	SELL	$225.79 - $275.2 $5.87 Million - $7.16 Million	-26,000 Reduced 15.83%	138,200 $33.4 Million
Q4 2022 Feb 02, 2023	BUY	$229.03 - $291.01 $7.56 Million - $9.6 Million	33,000 Added 25.15%	164,200 $43.1 Million
Q3 2022 Oct 17, 2022	BUY	$224.46 - $253.15 $1.75 Million - $1.97 Million	7,800 Added 6.32%	131,200 $29.6 Million
Q2 2022 Aug 11, 2022	SELL	$230.71 - $256.74 $2.75 Million - $3.06 Million	-11,900 Reduced 8.8%	123,400 $30 Million
Q1 2022 May 09, 2022	BUY	$219.27 - $242.57 $1.05 Million - $1.16 Million	4,800 Added 3.68%	135,300 $32.7 Million
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $1.77 Million - $2.03 Million	8,900 Added 7.32%	130,500 $29.4 Million
Q3 2021 Nov 10, 2021	SELL	$212.27 - $248.7 $3.1 Million - $3.63 Million	-14,600 Reduced 10.72%	121,600 $25.9 Million
Q2 2021 Aug 12, 2021	BUY	$233.58 - $259.14 $5.07 Million - $5.62 Million	21,700 Added 18.95%	136,200 $33.2 Million
Q1 2021 May 11, 2021	SELL	$221.91 - $258.6 $6.86 Million - $7.99 Million	-30,900 Reduced 21.25%	114,500 $28.5 Million
Q4 2020 Feb 09, 2021	BUY	$216.38 - $257.67 $8.05 Million - $9.59 Million	37,200 Added 34.38%	145,400 $33.4 Million
Q3 2020 Oct 22, 2020	BUY	$234.65 - $260.95 $1.43 Million - $1.59 Million	6,100 Added 5.97%	108,200 $27.5 Million
Q2 2020 Aug 11, 2020	BUY	$197.81 - $242.74 $6.73 Million - $8.25 Million	34,000 Added 49.93%	102,100 $24.1 Million
Q1 2020 May 04, 2020	BUY	$182.24 - $241.7 $12.4 Million - $16.5 Million	68,100 New	68,100 $13.8 Million

Others Institutions Holding AMGN

# of Institutions

3,080

Shares Held

404M

Call Options Held

7.56M

Put Options Held

7.16M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $147B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Forsta Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Forsta Ap Fonden with notifications on news.

Account